Related references
Note: Only part of the references are listed.CONGENITAL MALFORMATIONS AND MATERNAL CONSUMPTION OF BENZODIAZEPINES: A CASE-CONTROL STUDY
Liv Laegreid et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder
Sabine Wilhelm et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease
Nancy Frasure-Smith et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
A meta-analysis of D-Cycloserine and the facilitation of fear extinction and exposure therapy
Melissa M. Norberg et al.
BIOLOGICAL PSYCHIATRY (2008)
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder
Adam J. Guastella et al.
BIOLOGICAL PSYCHIATRY (2008)
Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study
Tim F. Oberlander et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: A flexible-dose, progressive-titration, placebo-controlled trial
Moira Rynn et al.
DEPRESSION AND ANXIETY (2008)
Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: Randomized, double-blind placebo-controlled study
Nadir A. Aliyev et al.
EUROPEAN PSYCHIATRY (2008)
Escitalopram in the treatment of obsessive–compulsive disorder
Joseph Zohar
Expert Review of Neurotherapeutics (2008)
Long-term efficacy of pregabalin in generalized anxiety disorder
Douglas Feltner et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
High-dose escitalopram for the treatment of obsessive-compulsive disorder
Ilan Rabinowitz et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Tiagabine in adult patients with generalized anxiety disorder - Results from 3 randomized, double-blind, placebo-controlled, parallel-group studies
Mark H. Pollack et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder
C. Allgulander et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Panic, suffocation false alarms, separation anxiety and endogenous opioids
Maurice Preter et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings
Naomi M. Simon et al.
PSYCHOPHARMACOLOGY (2008)
Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder
Bart J. Nuttin et al.
NEUROSURGERY (2008)
Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence
Derek Bolton et al.
JOURNAL OF BEHAVIOR THERAPY AND EXPERIMENTAL PSYCHIATRY (2008)
Anxiety as a developmental disorder
E. David Leonardo et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder
Sarah W. Book et al.
JOURNAL OF ANXIETY DISORDERS (2008)
Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients
Murray B. Stein et al.
JOURNAL OF TRAUMATIC STRESS (2007)
An open-label trial of escitalopram in children and adolescents with social anxiety disorder
Luciano Isolan et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
Non-inferiority trials are unethical because they disregard patients' interests
Silvio Garattini et al.
LANCET (2007)
A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder
John S. March et al.
BIOLOGICAL PSYCHIATRY (2007)
Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation
Perminder S. Sachdev et al.
PSYCHOLOGICAL MEDICINE (2007)
An effect-size analysis of pharmacologic treatments for generalized anxiety disorder
Rosario B. Hidalgo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
D-cycloserine augmented exposure therapy for obsessive-compulsive disorder
Matt G. Kushner et al.
BIOLOGICAL PSYCHIATRY (2007)
Quetiapine as monotherapy for social anxiety disorder: A placebo-controlled study
Sandeep Vaishnavi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents
Robert D. Gibbons et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders
Peter J. Norton et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2007)
The efficacy of milnacipran in panic disorder: an open trial
Carolina Blaya et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial
James Hartford et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study
Satoshi Asakura et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder - Results of a fixed-dose, placebo-controlled study
Ferenc Martenyi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: Two placebo-controlled trials
Moira A. Rynn et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia:: a randomized controlled trial
E. Mortberg et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder
Barbara Milrod et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: A meta-analysis of the randomized controlled trials
Petros Skapinakis et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2007)
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
Kerry J. Ressler et al.
NATURE NEUROSCIENCE (2007)
A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: Treatment effects and long-term maintenance
Bessel A. van der Kolk et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release
James M. Ferguson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder
Benjamin D. Greenberg et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials
Naomi A. Fineberg et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Prevention of relapse in generalized anxiety disorder by escitalopram treatment
Christer Allgulander et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
Borwin Bandelow et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women
Prasad R. Padala et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Memantine augmentation for refractory obsessive-compulsive disorder
Massimo Pasquini et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
M. H. Bloch et al.
MOLECULAR PSYCHIATRY (2006)
Cognitive therapy versus exposure and applied relaxation in social phobia: A randomized controlled trial
David M. Clark et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2006)
Venlafaxine extended release in posttraumatic stress disorder - A sertraline- and placebo-controlled study
Jonathan Davidson et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder
KP O'Connor et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: A 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine
Stuart A. Montgomery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder
SG Hofmann et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Olanzapine augmentation in treatment-resistant panic disorder - A 12-week, fixed-dose, open-label trial
G Sepede et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS)
A Mantovani et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Intensive cognitive-behavioral group treatment (CBGT) of social phobia: A randomized controlled study
Ewa Mortberg et al.
JOURNAL OF ANXIETY DISORDERS (2006)
Psychiatric manifestations of Graves' hyperthyroidism - Pathophysiology and treatment options
Robertas Bunevicius et al.
CNS DRUGS (2006)
Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome
MM Haby et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2006)
Treatment of obsessive-compulsive disorder: Cognitive behavior therapy vs. exposure and response prevention
ML Whittal et al.
BEHAVIOUR RESEARCH AND THERAPY (2005)
Risks associated with selective serotonin reuptake inhibitors in pregnancy
H Malm et al.
OBSTETRICS AND GYNECOLOGY (2005)
The selective GABA Reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: Results of a placebo-controlled study
MH Pollack et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Memantine for treatment-resistant OCD
M Poyurovsky et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
DS Baldwin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study
KA Kobak et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Adjunctive risperidone in generalized anxiety disorder: A double-blind, placebo-controlled study
O Brawman-Mintzer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Venlaflaxine extended-release capsules in panic disorder - Flexible-dose, double-blind, placebo-controlled study
J Bradwejn et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Pregabalin for treatment of generalized anxiety disorder - A 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam
K Rickels et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan
K Kamijima et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
V Coric et al.
BIOLOGICAL PSYCHIATRY (2005)
Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies
HU Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials
WK Goodman et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo
T Furmark et al.
BIOLOGICAL PSYCHIATRY (2005)
Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study
NA Fineberg et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Prevalence and treatment of mental disorders, 1990 to 2003
RC Kessler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Twelve-month use of Mental Health Services in the United States - Results from the National Comorbidity Survey Replication
PS Wang et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse
A McDonagh et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2005)
Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Efficacy of pregabalin in the treatment of generalized anxiety disorder - Double-blind, placebo-controlled comparison of BID versus TID dosing
RB Pohl et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Pilot study of community-based cognitive behavioral group therapy for adolescents with social phobia
S Baer et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2005)
Deep brain stimulation for refractory obsessive-compulsive disorder
JL Abelson et al.
BIOLOGICAL PSYCHIATRY (2005)
World Federation of Societies of Biological Psychiatry (WFSBP) - Guidelines for biological treatment of schizophrenia, part 1: Acute treatment of schizophrenia
P Falkai et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2005)
Potential effectiveness and safety of olanzapine in refractory panic disorder
M Hollifield et al.
DEPRESSION AND ANXIETY (2005)
A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia
K Mitte
JOURNAL OF AFFECTIVE DISORDERS (2005)
Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: An open-label study
AM Bogan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder
EB Foa et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study
S Erzegovesi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder - A placebo-controlled, multicenter study
AC Pande et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder
J Davidson et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder
HGM Westenberg et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia
JRT Davidson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Comparison of the treatment with paroxetine and reboxetine in panic disorder: A randomized, single-blind study
A Bertani et al.
PHARMACOPSYCHIATRY (2004)
The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease
B Bankier et al.
PSYCHOSOMATIC MEDICINE (2004)
A comparison of narrative exposure therapy, supportive counseling, and psychoeducation for treating posttraumatic stress disorder in an African refugee settlement
F Neuner et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2004)
An open trial of topiramate in the treatment of generalized social phobia
M Van Ameringen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder
KD Wagner et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants
AM Weissman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial
DA Geller et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2004)
Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study
JRT Davidson et al.
DEPRESSION AND ANXIETY (2004)
A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder
K Rickels et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Cognitive therapy versus fluoxetine in generalized social phobia: A randomized placebo-controlled trial
DM Clark et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2003)
Anxiety and chronic obstructive pulmonary disease: Prevalence, impact, and treatment
GA Brenes
PSYCHOSOMATIC MEDICINE (2003)
Tiagabine for the treatment of generalized anxiety disorder: A randomized, open-label, clinical trial with paroxetine as a positive control
M Rosenthal
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study
S Seedat et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder
MH Pollack et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Group cognitive-behavioral therapy for generalized anxiety disorder:: Treatment outcome and long-term follow-up
MJ Dugas et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2003)
Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder
BJ Nuttin et al.
NEUROSURGERY (2003)
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder
E Hollander et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Cognitive therapy versus applied relaxation as treatment of generalized anxiety disorder
A Arntz
BEHAVIOUR RESEARCH AND THERAPY (2003)
Fluoxetine for the treatment of childhood anxiety disorders
B Birmaher et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2003)
Comparative efficacy, speed, and adverse effects of three PTSD treatments: Exposure therapy, EMDR, and relaxation training
S Taylor et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2003)
Cognitive-behavioral treatment of late-life generalized anxiety disorder
MA Stanley et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2003)
Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study
K Rickels et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Anterior cingulotomy for refractory obsessive-compulsive disorder
CH Kim et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial
TT Haug et al.
BRITISH JOURNAL OF PSYCHIATRY (2003)
Deep brain stimulation for treatment-refractory obsessive-compulsive disorder:: psychopathological and neuropsychological outcome in three cases
L Gabriëls et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder
F Stocchi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Pregabalin in generalized anxiety disorder: A placebo-controlled trial
AC Pande et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Quetiapine treatment in patients with posttraumatic stress disorder: An open trial of adjunctive therapy
MB Hamner et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
G Vaiva et al.
BIOLOGICAL PSYCHIATRY (2003)
Treating medication-resistant panic disorder: Predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital
E Heldt et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2003)
Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial
DJ Stein et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
A controlled evaluation of cognitive behaviorial therapy for posttraumatic stress in motor vehicle accident survivors
EB Blanchard et al.
BEHAVIOUR RESEARCH AND THERAPY (2003)
Efficacy of paroxetine for relapse prevention in social anxiety disorder - A 24-week study
DJ Stein et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Fluoxetine in children and adolescents with OCD: A placebo-controlled trial
MR Liebowitz et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study
I Nulman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: A 3-month double-blind study
PM Llorca et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12-week, controlled study
U Albert et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: A double-blind, placebo-controlled study
MB Stein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Single session debriefing after psychological trauma: a meta-analysis
AAP van Emmerik et al.
LANCET (2002)
A controlled comparison of eye movement desensitization and reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder
K Power et al.
CLINICAL PSYCHOLOGY & PSYCHOTHERAPY (2002)
Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control
JH Greist et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder
DD Dougherty et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
RK Pitman et al.
BIOLOGICAL PSYCHIATRY (2002)
Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder
N Mohr et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
MM Iqbal et al.
PSYCHIATRIC SERVICES (2002)
Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: A preliminary report
J Berlant et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: Pooled analysis of five randomized placebo-controlled clinical trials
IR Katz et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
Generalized anxiety disorder: Prevalence, burden, and cost to society
HU Wittchen
DEPRESSION AND ANXIETY (2002)
Comparison of two treatments for traumatic stress: A community-based study of EMDR and prolonged exposure
G Ironson et al.
JOURNAL OF CLINICAL PSYCHOLOGY (2002)
The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors
G Schelling et al.
BIOLOGICAL PSYCHIATRY (2001)
Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder
MA Rynn et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder - Randomised, placebo-controlled trial
D Michelson et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study
RD Marshall et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week double-blind, placebo-controlled study
J Davidson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo-controlled, flexible-dosage trial
P Tucker et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Sertraline treatment of panic disorder: results of a long-term study
MH Rapaport et al.
ACTA PSYCHIATRICA SCANDINAVICA (2001)
Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients
GM Asnis et al.
PSYCHIATRY RESEARCH (2001)
Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia
S Blomhoff et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Early coadministration of clonazepam with sertraline for panic disorder
AW Goddard et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder - Twenty-four-week placebo-controlled dose-ranging study
C Allgulander et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial
DA Geller et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)
Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder
A Palatnik et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Psychological and pharmacological treatments of social phobia: A meta-analysis
IC Fedoroff et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study
G Perna et al.
PHARMACOPSYCHIATRY (2001)
Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder
PD McLean et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2001)
Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study
MA Van Ameringen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial
MA Riddle et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)
Opipramol for the treatment of generalized anxiety disorder:: A placebo-controlled trial including an alprazolam-treated group
HJ Möller et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Inositol in the treatment of trichotillomania and compulsive skin picking
S Seedat et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Prevention of relapse in generalized social phobia: Results of a 24-week study in responders to 20 weeks of sertraline treatment
JR Walker et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder:: Evaluation in a controlled clinical trial
R Ladouceur et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2000)
Fluoxetine - A review of its use in women's health
K Simpson et al.
CNS DRUGS (2000)
Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial
S Hirschmann et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Applied relaxation vs. cognitive therapy in the treatment of generalized anxiety disorder
LG Öst et al.
BEHAVIOUR RESEARCH AND THERAPY (2000)
Flawed meta-analyses comparing psychotherapy with pharmacotherapy
DF Klein
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
LM Koran et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Psychological debriefing for road traffic accident victims - Three-year follow-up of a randomised controlled trial
RA Mayou et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Cognitive-behavioral group therapy for social phobia in female adolescents: Results of a pilot study
C Hayward et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2000)
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder - A randomized controlled trial
DH Barlow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Efficacy and safety of sertraline treatment of posttraumatic stress disorder - A randomized controlled trial
K Brady et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Neuroanatomical hypothesis of panic disorder, revised
JM Gorman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Cognitive behavior therapy versus supportive therapy in social phobia:: A randomized controlled trial
J Cottraux et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2000)
Low dopamine D-2 receptor binding potential in social phobia
FR Schneier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly
G Emslie et al.
ACTA PSYCHIATRICA SCANDINAVICA (2000)
Share Paper
